7 authorised products containing Ranibizumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Byooviz 10 mg/ml solution for injection EU/1/21/1572/001 |
Ranibizumab | Samsung Bioepis NL B.V. | — |
| Epruvy 10 mg/ml solution for injection (previously Ranibizumab Midas) EU/1/24/1860/001 |
Ranibizumab | Midas Pharma GmbH | — |
| Lucentis 10 mg/ml solution for injection EU/1/06/374/002-004 |
Ranibizumab | Novartis Europharm Limited | — |
| Ranivisio 10 mg/ml solution for injection EU/1/22/1673/001 |
Ranibizumab | Midas Pharma GmbH | — |
| Rimmyrah EU/1/23/1779/001-002 |
Ranibizumab | Qilu Pharma Spain S.L. | — |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/001 |
Ranibizumab | Stada Arzneimittel AG | — |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/002 |
Ranibizumab | Stada Arzneimittel AG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.